SCHEMBL3852013

SCHEMBL3852013

CSc1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(CN(C)C)cc4)cc23)s1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 13/20 0.35
CYP1A2 P05177 11/20 0.35
CYP3A4 P08684 11/20 0.35
CLK4 Q9HAZ1 3/20 0.35
CYP2C19 P33261 7/20 0.34
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 1/20 0.34
KDM4E B2RXH2 2/20 0.32
USP2 O75604 3/20 0.32
HPGD P15428 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 3/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
AURKA O14965 1/20 0.30
AURKB Q96GD4 1/20 0.30
MAPK1 P28482 1/20 0.30
GLA P06280 1/20 0.30
CYP2C9 P11712 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845563 0.91 EGFR (0.33)
SCHEMBL3851042 0.90 CYP1A2 (0.35) CYP2D6CYP1A2CYP3A4CLK4CYP2C19
SCHEMBL3846535 0.89 PIK3CD (0.32) CYP2D6CYP1A2CYP3A4CLK4CYP2C19
SCHEMBL3852824 0.88 KDM4E (0.33) CYP2D6CYP1A2CYP3A4CLK4CYP2C19
SCHEMBL4716874 0.87 CYP3A4 (0.33) CYP2D6CYP1A2CYP3A4CLK4CYP2C19
SCHEMBL3855612 0.87 MAP4K4 (0.34) CYP2D6CYP1A2CYP3A4CLK4CYP2C19
SCHEMBL3855222 0.86 CYP1A2 (0.34) CYP2D6CYP1A2CYP3A4CLK4CYP2C19
SCHEMBL3846715 0.85 F2RL3 (0.33) CYP2D6CYP1A2CYP3A4CLK4CYP2C19
SCHEMBL3846175 0.84 TGFBR1 (0.31)
SCHEMBL3856406 0.84 AURKA (0.35) CYP2D6CYP1A2CYP3A4CLK4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed